Type 1 diabetes: pathogenesis and prevention
Open Access
- 27 June 2006
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 175 (2), 165-170
- https://doi.org/10.1503/cmaj.060244
Abstract
Type 1 diabetes results from the autoimmune destruction of insulin-producing β cells in the pancreas. Genetic and, as yet undefined, environmental factors act together to precipitate the disease. The excess mortality associated with the complications of type 1 diabetes and the increasing incidence of childhood type 1 diabetes emphasize the importance of therapeutic strategies to prevent this chronic disorder. Why is it considered that type 1 diabetes might be preventable? Different strands of diabetes research are coming together to suggest therapeutic targets. Islet cell autoantibody assays make it possible to accurately identify people at risk of future disease. In most cases, a long prodrome provides a window of opportunity to reverse the autoimmune process. Although no current “cure” exists, recent genetic data and preliminary trial results suggest T cells as a target for preventive strategies. Another potentially attainable target is induction of tolerance to the β-cell proteins such as insulin that are inappropriately recognized. Other strategies involve β-cell replacement, but currently there are insufficient donor cells available. This may be overcome as the processes controlling the differentiation of pancreatic and nonpancreatic progenitors as well as replication of existing islet β cells are unravelled.Keywords
This publication has 80 references indexed in Scilit:
- Association ofCTLA4 polymorphism with regulatory T cell frequencyEuropean Journal of Immunology, 2005
- A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetesNature Genetics, 2004
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000Diabetes Care, 2002
- Regulatory T Cells: Key Controllers of Immunologic Self-ToleranceCell, 2000
- Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.Diabetes Care, 1999
- Insulitis in type 1 (insulin‐dependent) diabetes mellitus in man—macrophages, lymphocytes, and interferon‐γ containing cellsThe Journal of Pathology, 1991
- Insulin autoantibodies: Their role in the pathogenesis of IDDMDiabetes/Metabolism Research and Reviews, 1987
- Diabetes Mellitus and Autoimmunity in Patients with the Congenital Rubella SyndromeClinical Infectious Diseases, 1985
- ST. BARTHOLOMEW'S HOSPITAL.The Lancet, 1824